美股市场个股详情

BPTH Bio-Path Holdings

添加自选

2.160
-0.420-16.28%

交易中 05/15 14:42 (美东)

357.75万总市值-85市盈率TTM

Bio-Path Holdings股票讨论区

登录发表评论

Jaguar8

04/20 01:00

$Bio-Path Holdings(BPTH.US)$
NEWS
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

70959052

04/20 00:25

$Bio-Path Holdings(BPTH.US)$ offering closed pump to be resumed

Stock Region

04/19 23:29

Biotechnology Company Announces Successful Clinical Trial Completion For Leukemia Treatment

A Beacon of Hope: Bio-Path Holdings' Groundbreaking Progress in AML Treatment.
In a significant stride toward combating refractory/relapsed acute myeloid leukemia (AML), Bio-Path Holdings, Inc. has recently announced the successful completion of the second dose cohort in the dose escalation portion of its Phase 1/1b clinical trial of BP1002. This marks a pivotal moment in the ongoing battle against one of...